To Attract In-Home Caregivers, California Offers Paid Training — And Self-Care
Turnover ails a program that allows low-income people who are older or disabled to age in place. To attract new workers and improve retention, the state is paying caregivers to develop new skills.
KHN’s ‘What the Health?’: Congress Races the Clock
Sen. Raphael Warnock’s re-election in Georgia will give Democrats a clear-cut Senate majority for the first time in nearly a decade. Meanwhile, the current Congress has only days left to tackle major unfinished business on the health agenda, including fending off scheduled pay cuts for doctors and other health providers in the Medicare program. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Anna Edney of Bloomberg News, and Sandhya Raman of CQ Roll Call join KHN’s Julie Rovner to discuss these topics and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
A Family Death During the Holidays Prompts Questions and Reflection
The death of a sharp but frail patriarch just days before Thanksgiving casts a shadow on a family’s holiday season.
For Patients With Sickle Cell Disease, Fertility Care Is About Reproductive Justice
The disease, which predominantly affects Black patients, can damage the body in ways that can make having a child difficult. But patients don’t always have access to fertility care.
Paxlovid Has Been Free So Far. Next Year, Sticker Shock Awaits.
The government soon will stop paying for the covid drug that has proved to be the most effective at keeping patients alive and out of the hospital.
Watch: Big Medicaid Changes in California Leave Millions of Patients Behind
California Healthline senior correspondent Angela Hart discusses how California’s big Medicaid experiment to bring social services to the sickest and costliest patients doesn’t help most patients.
Employers Use Patient Assistance Programs to Offset Their Own Costs
Some insurers and employers are tapping into assistance programs meant for individual patients. The concern: Some costly drugs could be harder for patients to access.
